*.- The "National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology" on uterine neoplasms highly recommends the inclusion of patients in clinical trials with Yondelis® to treat uterine leiomyosarcoma.
*.- Leiomyosarcomas are aggressive tumours that are often difficult to treat.
*.- The NCCN is a not-for-profit alliance of 23 of the world's leading cancer centres devoted to research, and education and patient care.
...